Instead, its added as a booster, or push, toward the end of an IV session
Clinical Update 5/12/2026 Caution With GLP-1s and Lithium Starting or switching GLP-1s while on lithium may cause serious side effects, according to several reports
Severe nausea requiring treatment discontinuation was rare in monotherapy trials, with only about 1% of participants in the REDEFINE 1 trial stopping treatment because of adverse events overall
For your convenience, we have included a fax template that lists common dosing in the Resources for Providers section above
To reduce the complexity of the microbial community, single colonies, groups of 23 colonies, and groups of 4+ colonies totaling 768 cultures were then picked and inoculated into 1 ml of BHI containing 50 M d 9 -l-carnitine